PT980254E - Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral - Google Patents

Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral

Info

Publication number
PT980254E
PT980254E PT98925588T PT98925588T PT980254E PT 980254 E PT980254 E PT 980254E PT 98925588 T PT98925588 T PT 98925588T PT 98925588 T PT98925588 T PT 98925588T PT 980254 E PT980254 E PT 980254E
Authority
PT
Portugal
Prior art keywords
viral
glycyclic
comprehending
acid
pharmaceutical composition
Prior art date
Application number
PT98925588T
Other languages
English (en)
Portuguese (pt)
Inventor
Raffaello Pompei
Mario Pinza
Original Assignee
Aziende Chimiche R A Francesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche R A Francesco filed Critical Aziende Chimiche R A Francesco
Publication of PT980254E publication Critical patent/PT980254E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98925588T 1997-05-14 1998-05-06 Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral PT980254E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (it) 1997-05-14 1997-05-14 Composizione farmaceutica antivirale comprendente acido glicirrizico ed almeno una proteina dotata di attivita' antivirale

Publications (1)

Publication Number Publication Date
PT980254E true PT980254E (pt) 2002-07-31

Family

ID=11377123

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98925588T PT980254E (pt) 1997-05-14 1998-05-06 Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral

Country Status (26)

Country Link
US (1) US6329339B1 (instruction)
EP (1) EP0980254B1 (instruction)
JP (2) JP2001525814A (instruction)
KR (1) KR100592193B1 (instruction)
CN (1) CN1114447C (instruction)
AR (1) AR012849A1 (instruction)
AT (1) ATE212232T1 (instruction)
AU (1) AU740944B2 (instruction)
BG (1) BG64748B1 (instruction)
CA (1) CA2289550A1 (instruction)
CZ (1) CZ291932B6 (instruction)
DE (1) DE69803565T2 (instruction)
DK (1) DK0980254T3 (instruction)
EA (1) EA003126B1 (instruction)
ES (1) ES2170501T3 (instruction)
GE (1) GEP20022672B (instruction)
HU (1) HU224956B1 (instruction)
IL (2) IL132651A0 (instruction)
IT (1) IT1291366B1 (instruction)
PL (1) PL189218B1 (instruction)
PT (1) PT980254E (instruction)
SK (1) SK283584B6 (instruction)
TR (1) TR199902730T2 (instruction)
UA (1) UA63955C2 (instruction)
WO (1) WO1998051334A1 (instruction)
ZA (1) ZA983917B (instruction)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
AU2003225073A1 (en) * 2002-04-18 2003-11-03 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
WO2005026209A2 (en) * 2003-09-11 2005-03-24 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
US7964706B2 (en) * 2004-10-22 2011-06-21 Medimmune, Llc High affinity antibodies against HMGB1 and methods of use thereof
EP1909834A2 (en) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
IT1391170B1 (it) * 2008-08-07 2011-11-18 D M G Italia S R L Composizione topica intra-nasale utilizzabile in caso di ostruzione nasale
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
EP2608783B1 (en) * 2010-08-25 2018-09-19 Lurong Zhang Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
EP3108894B1 (en) 2014-02-21 2022-01-26 Kewpie Corporation Non-therapeutic method of deactivating norovirus, use of lysozyme component for non-therapeutic norovirus deactivation, and lysozyme component for use in the prevention or treatment of norovirus infection
CN117942405A (zh) * 2016-02-25 2024-04-30 应用生物实验室公司 保护空气传播的病原体和刺激物的组合物和方法
CN109022351B (zh) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 重组人溶菌酶的新应用
CN112135625B (zh) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 一种预防或治疗covid-19新冠肺炎的药物及其应用
EP3928785B1 (en) * 2020-04-27 2024-07-31 Guangzhou Century Clinical Research Co., Ltd Medicament and food for use in preventing or treating novel coronavirus pneumonia covid-19
CN117898418A (zh) * 2020-04-27 2024-04-19 湘北威尔曼制药股份有限公司 一种对新冠病毒损伤有辅助保护作用的食物及其应用
MX2021005280A (es) 2021-05-04 2022-02-23 Spv Timser S A P I De C V Composicion farmaceutica que contiene triterpenoides pentaciclicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
JP2838720B2 (ja) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 安定な点眼剤
JP4056099B2 (ja) * 1996-05-09 2008-03-05 森永乳業株式会社 水生動物の寄生生物性疾患の予防および治療剤

Also Published As

Publication number Publication date
KR20010012419A (ko) 2001-02-15
AU740944B2 (en) 2001-11-15
UA63955C2 (uk) 2004-02-16
CZ291932B6 (cs) 2003-06-18
EA199901024A1 (ru) 2000-06-26
AR012849A1 (es) 2000-11-22
BG103968A (en) 2000-07-31
SK283584B6 (sk) 2003-10-07
HK1028347A1 (en) 2001-02-16
ZA983917B (en) 1998-11-09
EA003126B1 (ru) 2003-02-27
DE69803565T2 (de) 2002-08-08
IL132651A (en) 2006-10-31
KR100592193B1 (ko) 2006-06-23
HUP0002985A3 (en) 2001-04-28
DK0980254T3 (da) 2002-05-06
ITMI971119A0 (instruction) 1997-05-14
JP2009102370A (ja) 2009-05-14
SK154499A3 (en) 2000-08-14
ES2170501T3 (es) 2002-08-01
PL336802A1 (en) 2000-07-17
CA2289550A1 (en) 1998-11-19
TR199902730T2 (xx) 2000-02-21
ITMI971119A1 (it) 1998-11-14
JP2001525814A (ja) 2001-12-11
US6329339B1 (en) 2001-12-11
IT1291366B1 (it) 1999-01-07
CN1114447C (zh) 2003-07-16
AU7764698A (en) 1998-12-08
BG64748B1 (bg) 2006-02-28
WO1998051334A1 (en) 1998-11-19
ATE212232T1 (de) 2002-02-15
EP0980254B1 (en) 2002-01-23
HUP0002985A2 (hu) 2001-01-29
PL189218B1 (pl) 2005-07-29
DE69803565D1 (de) 2002-03-14
CZ399199A3 (cs) 2000-04-12
IL132651A0 (en) 2001-03-19
GEP20022672B (en) 2002-04-25
EP0980254A1 (en) 2000-02-23
CN1255859A (zh) 2000-06-07
HU224956B1 (en) 2006-04-28

Similar Documents

Publication Publication Date Title
PT980254E (pt) Composicao farmaceutica anti-viral compreendendo acido glicirizico e pelo menos uma proteina dotada de actividade anti-viral
BR9702808A (pt) Utilização de pelo menos um retinóide apresentando uma atividade anti-ap-1
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
FI20031199A7 (fi) Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia
IT8519353A0 (it) Composizione farmaceutica e forme farmaceutiche che la contengono
FI943745L (fi) Koostumuksia ja menetelmiä proteiinin rakenteen määrityksiin
BR1100824A (pt) Composto e composição farmacêutica
ID30181A (id) Asam antranilat- dan asam tioantranilat-n-aril amida
FI944448L (fi) Stabiloitu farmaseuttinen koostumus ja stabiloiva liuotin
FI944832A0 (fi) Farmaseuttinen koostumus
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
NO20002038D0 (no) Uløselig insulinsammensetning
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
ITMI962505A0 (it) Nuovi esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
ITMI932540A0 (it) Composizione farmaceutica
PT878467E (pt) Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos
DE69527764D1 (de) Backtriebsäurezusammensetzung
ID29294A (id) Komposisi farmasi
FI971427L (fi) Peptidit ja niitä sisältävät farmaseuttiset koostumukset
ES2142840T3 (es) Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen.
LV10579A (lv) Farmaceitiska kompozicija
ATA231194A (de) Häcksler
ID23531A (id) Komposisi farmasi
BR9505130A (pt) Composto e composiçao farmacêutica